Does POMALIDOMIDE Cause Progressive multifocal leukoencephalopathy? 135 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 135 reports of Progressive multifocal leukoencephalopathy have been filed in association with POMALIDOMIDE (Pomalyst). This represents 0.2% of all adverse event reports for POMALIDOMIDE.
135
Reports of Progressive multifocal leukoencephalopathy with POMALIDOMIDE
0.2%
of all POMALIDOMIDE reports
41
Deaths
62
Hospitalizations
How Dangerous Is Progressive multifocal leukoencephalopathy From POMALIDOMIDE?
Of the 135 reports, 41 (30.4%) resulted in death, 62 (45.9%) required hospitalization, and 27 (20.0%) were considered life-threatening.
Is Progressive multifocal leukoencephalopathy Listed in the Official Label?
Yes, Progressive multifocal leukoencephalopathy is listed as a known adverse reaction in the official FDA drug label for POMALIDOMIDE.
What Other Side Effects Does POMALIDOMIDE Cause?
Plasma cell myeloma (7,023)
Death (6,795)
Fatigue (6,530)
Pneumonia (5,792)
Off label use (3,845)
Diarrhoea (3,351)
White blood cell count decreased (3,328)
Neutropenia (3,029)
Rash (2,715)
Dyspnoea (2,543)
What Other Drugs Cause Progressive multifocal leukoencephalopathy?
NATALIZUMAB (1,668)
RITUXIMAB (1,647)
CYCLOPHOSPHAMIDE (782)
PREDNISONE (606)
PREDNISOLONE (439)
TACROLIMUS (438)
METHOTREXATE (428)
DOXORUBICIN (421)
MYCOPHENOLATE MOFETIL (414)
VINCRISTINE (376)
Which POMALIDOMIDE Alternatives Have Lower Progressive multifocal leukoencephalopathy Risk?
POMALIDOMIDE vs POMALYST
POMALIDOMIDE vs PONATINIB
POMALIDOMIDE vs PONATINIB\PONATINIB
POMALIDOMIDE vs PONESIMOD
POMALIDOMIDE vs PORACTANT ALFA